Skip to main content
Indo Amines Ltd. logo

Indo Amines Ltd. — Investor Relations & Filings

Ticker · INDOAMIN ISIN · INE760F01028 LEI · 3358008TWXJQJZ37YA37 BSE.NS Manufacturing
Open in API
Filings indexed 375 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS INDOAMIN

About Indo Amines Ltd.

https://indoaminesltd.com/

Indo Amines Ltd. is a manufacturer and exporter of fine, specialty, and performance chemicals, specializing in fatty amines and their derivatives. The company's product portfolio includes quaternary ammonium compounds, amine ethoxylates, and various specialty chemicals designed for diverse industrial applications. These products serve sectors such as pharmaceuticals, agrochemicals, water treatment, personal care, home care, and oilfield chemicals. Indo Amines utilizes research and development capabilities to provide custom synthesis and contract manufacturing services, ensuring technical precision and quality standards. By focusing on innovation and process efficiency, the company supplies essential chemical intermediates and performance-enhancing additives to a global market, emphasizing technical support and specialized chemical solutions.

Recent filings

Filing Released Lang Actions
Options to purchase securities
Regulatory Filings Classification · 85% confidence The document is a compliance filing to stock exchanges under SEBI Listing Regulations announcing the outcome of a Board meeting held on May 26, 2026. It covers multiple regulatory disclosures: approval of audited standalone and consolidated financial results (with audit reports attached), recommendation of a final dividend, re-appointments of cost and internal auditors, re-appointment of a whole-time director, grant of employee stock options, and meeting timings. This is not the full annual report or its detailed financial statements (only the results are attached as annexures), nor is it merely a proxy or earnings release. It is a general regulatory announcement under Listing Obligations and Disclosure Requirements and does not fit any more specific category, so it falls under the fallback “Regulatory Filings” category (RNS).
2026-05-26 English
Please find attached herewith intimation related to approval by Nomination and Remuneration Committee and noting by Board the grant of 560,000 Stock Options under Indo Amines Limited Employee ....
Regulatory Filings Classification · 85% confidence The document is an announcement to stock exchanges under SEBI Listing Regulations (Regulation 30 & 33) describing the outcome of a Board meeting – including audited financial results, dividend recommendation, auditor appointments, director re-appointment, and ESOP grant. It does not itself contain the full annual or quarterly financial report text, nor is it solely a dividend notice or board change proxy; rather, it is a regulatory disclosure of multiple items. Under our taxonomy, this falls under general regulatory announcements (RNS).
2026-05-26 English
Please find attached herewith outcome of the Board Meeting held on Tuesday, 26th May, 2026
Regulatory Filings Classification · 88% confidence The document is a formal SEBI Listing Regulations disclosure titled “Outcome of Board Meeting” submitted to BSE/NSE. It lists board approvals of audited financial results, audit reports, dividend recommendation, re-appointments of auditors/directors, and ESOP grants. This type of continuous disclosure to the stock exchange does not itself contain the full Annual or Interim Report text, is not a proxy or AGM material, not an earnings-only highlights release, nor a standalone audit opinion. It is a general regulatory announcement under Listing Obligations, fitting the fallback “Regulatory Filings” category.
2026-05-26 English
Please find attached herewith financial results for the year ended 31st March, 2026
Interim / Quarterly Report Classification · 85% confidence The document is the official Board Meeting outcome under SEBI Listing Regulations 30 & 33, enclosing the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 along with the Independent Auditor’s Report and full financial statement tables. It is not a brief earnings release, proxy or dividend notice, nor a full Annual Report (10-K); instead it provides substantive financial disclosures for a period shorter than or up to a full fiscal year. Therefore it fits the definition of an Interim / Quarterly Report. FY 2026
2026-05-26 English
Outcome of Board Meeting
Regulatory Filings
2026-05-26 English
please find attached herewith outcome of the Board Meeting held on Tuesday, 26th May, 2026.
Interim / Quarterly Report Classification · 85% confidence The document is a lengthy SEBI-regulated disclosure of audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, including complete audit reports and detailed financial statement tables. It is not merely an announcement pointing to another report (so not RPA/RNS), nor a full annual report (10-K), nor just highlights (ER). It contains substantive financial data and analysis for a period shorter than a full fiscal year (the quarter) plus year‐end results in a single statement. Therefore, it aligns with an Interim/Quarterly Report filing (IR). FY 2026
2026-05-26 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.